{"gene":"TAF1A","run_date":"2026-06-10T10:51:54","timeline":{"discoveries":[{"year":1995,"finding":"TAFI48 (TAF1A) serves as a direct target for interaction with UBF within the SL1 complex and is required to form a transcriptionally active SL1 complex responsive to UBF in vitro; additionally, TAFI48 alters TBP's ability to interact with TATA box elements such that the resulting complex fails to support RNA polymerase II transcription, establishing TAFI48 as both a UBF coactivator target and a class-specific promoter selectivity factor.","method":"In vitro transcription assays, protein-protein interaction assays, promoter contact studies","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro transcription reconstitution with purified components, multiple functional readouts, foundational study replicated conceptually by subsequent work","pmids":["7491500"],"is_preprint":false},{"year":1994,"finding":"UV crosslinking experiments demonstrated that TAFI48 directly contacts the ribosomal gene promoter DNA, establishing it as one of two TAFs responsible for promoter DNA binding within the SL1/TIF-IB complex. This DNA-binding activity of the TAFs (not TBP's N-terminal domain) underlies species-specific rDNA promoter selectivity.","method":"UV crosslinking, chimeric SL1 complex reconstitution, in vitro transcription","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct UV crosslinking to promoter DNA with reconstituted complexes; mechanistic conclusion supported by multiple experimental approaches in one study","pmids":["8013460"],"is_preprint":false},{"year":1994,"finding":"In vitro protein-protein interaction assay demonstrated that TBP directly interacts with the smallest TAF subunit TAFI48; furthermore, the conserved core domain of TBP alone (lacking the N-terminal domain) is sufficient to assemble an SL1 complex containing all three TAFs including TAFI48.","method":"In vitro protein-protein interaction assay, immunopurification of epitope-tagged TBP complexes, in vitro transcription","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro binding assay plus functional transcription reconstitution, multiple orthogonal methods","pmids":["8058785"],"is_preprint":false},{"year":1997,"finding":"SV40 large T antigen directly binds TAF(I)48 (as well as TBP and TAF(I)110) within the SL1 complex, both in vitro and in SV40-infected cells; large T antigen mutants that no longer bind SL1 also fail to stimulate Pol I transcription, establishing that T antigen recruitment to the rRNA promoter via SL1/TAF(I)48 is required for Pol I transcriptional activation.","method":"Immunoprecipitation (in vitro and in infected cells), in vitro transcription with T antigen deletion mutants","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — reciprocal immunoprecipitation in vitro and in vivo, combined with functional transcription assays using deletion mutants establishing necessity","pmids":["9203586"],"is_preprint":false},{"year":1999,"finding":"The abundance of TAFI48 (along with TAFI95) decreases during differentiation of F9 embryonal carcinoma cells into parietal endoderm, and this reduction is associated with decreased RNA polymerase I transcription, demonstrating that developmental regulation of rRNA synthesis is achieved in part through changes in TAFI48 availability.","method":"Cell differentiation model, quantification of SL1 subunit levels, in vitro transcription","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — defined cellular differentiation model with measurement of both protein levels and transcriptional output, single lab","pmids":["9933634"],"is_preprint":false},{"year":2004,"finding":"TAF(I)48 directly interacts with the N-terminal segment of the Pol I-associated factor PAF49/ASE-1; this interaction also co-precipitates other SL1 components, linking PAF49 to the SL1 complex through TAF(I)48.","method":"Coimmunoprecipitation, domain-mapping of PAF49, in vitro protein interaction assays, in vitro transcription with inhibitory antibody","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — coimmunoprecipitation with domain mapping and functional transcription assay, single lab","pmids":["15226435"],"is_preprint":false},{"year":2004,"finding":"The carboxyl-terminal 51 residues of TAF(I)48 are necessary and sufficient for nuclear and nucleolar localization; this region also associates with multiple beta-karyopherin nuclear import receptors (importin beta/karyopherin beta1, transportin/karyopherin beta2, RanBP5/karyopherin beta3) in a Ran-dependent manner, identifying the first nuclear import sequence within an SL1 TAF subunit.","method":"GFP fusion domain-deletion analysis, co-precipitation with importins, Ran-dependence assay, immunolocalization","journal":"Journal of biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct subcellular localization with domain deletion and multiple importin binding assays, single lab","pmids":["15113842"],"is_preprint":false},{"year":2004,"finding":"A TBP-binding domain was mapped to the carboxyl-terminus of human TAF(I)48; mutagenesis of uncharged and positive residues in this region disrupted TBP binding; TBP residues within and adjacent to helix 2 (previously shown to contact TFIID and TFIIIB subunits) also reduced affinity for the TAF(I)48 carboxyl-terminus.","method":"Yeast two-hybrid, direct protein-protein interaction assay, site-directed mutagenesis of both TAF(I)48 and TBP","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — mutagenesis combined with direct binding assay, but single lab and abstract-level detail","pmids":["15315821"],"is_preprint":false},{"year":2017,"finding":"Compound heterozygous recessive mutations in TAF1A in two sisters with end-stage pediatric dilated cardiomyopathy were associated with gene-specific nucleolar segregation defects in cardiomyocytes (indicative of impaired rRNA synthesis); knockout of the homologous gene in zebrafish recapitulated heart failure with pericardial edema, decreased ventricular systolic function, and embryonic mortality.","method":"Whole exome sequencing, cardiac histopathology (nucleolar segregation), zebrafish knockout with cardiac phenotype readout","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function in zebrafish with defined cardiac phenotype plus human tissue pathology, single lab","pmids":["28472305"],"is_preprint":false},{"year":2025,"finding":"DCAF13 directly interacts with TAF1A, a component of the RNA polymerase I preinitiation complex, and this interaction is necessary for preinitiation complex assembly at the rDNA promoter; DCAF13 knockdown impairs rDNA transcription, ribosome biogenesis, and protein synthesis.","method":"Co-immunoprecipitation (direct interaction), knockdown functional assays (rDNA transcription, ribosome biogenesis, protein synthesis)","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding demonstrated by co-IP with functional knockdown readouts, single lab","pmids":["40902972"],"is_preprint":false},{"year":2024,"finding":"The lncRNA LINC01116 scaffolds TAF1A and TAF1D to the ribosomal DNA promoter, as demonstrated by RNA immunoprecipitation and chromatin isolation by RNA purification (ChIRP); this scaffolding activity upregulates Pol I transcription and drives oncogenic phenotypes in lung adenocarcinoma cells.","method":"RNA immunoprecipitation, ChIRP, ChIP, lncRNA knockdown/overexpression with Pol I transcription readout","journal":"Journal of translational medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal chromatin/RNA binding methods, single lab","pmids":["39369230"],"is_preprint":false},{"year":2006,"finding":"Nucleophosmin (NPM) is required for a G2/M upregulation of TAF1A mRNA; siRNA depletion of NPM abolishes this cell-cycle-dependent increase in TAF1A expression, placing NPM upstream of TAF1A in the regulation of rDNA transcription machinery.","method":"siRNA knockdown of NPM, microarray and gene expression profiling, cell cycle analysis","journal":"Experimental cell research","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single indirect measure of TAF1A mRNA regulation, no direct mechanistic dissection of TAF1A protein function","pmids":["17069796"],"is_preprint":false}],"current_model":"TAF1A (TAFI48) is the 48-kDa subunit of the RNA polymerase I-specific promoter selectivity factor SL1, where it directly contacts rDNA promoter sequences, serves as the target for UBF coactivator interaction to enable UBF-responsive Pol I transcription, directly binds TBP through its carboxyl-terminal domain (engaging TBP helix 2), associates with PAF49/ASE-1 and DCAF13 to facilitate preinitiation complex assembly, and is directed to the nucleolus via a C-terminal nuclear localization sequence that engages multiple beta-karyopherin importins; loss of TAF1A function in humans and zebrafish causes impaired rRNA synthesis with cardiac ribosomopathy phenotypes."},"narrative":{"mechanistic_narrative":"TAF1A (TAFI48) is a TBP-associated subunit of the RNA polymerase I promoter selectivity factor SL1, where it confers class-specific recognition of the ribosomal RNA gene promoter and couples this machinery to transcriptional activation [PMID:7491500, PMID:8013460]. Within SL1 it directly contacts rDNA promoter DNA, an activity (rather than TBP's N-terminus) that underlies species-specific promoter selectivity [PMID:8013460], and it binds TBP through its carboxyl-terminal domain engaging residues in and around TBP helix 2, while also remodeling TBP so the resulting complex no longer supports Pol II transcription [PMID:7491500, PMID:15315821]. TAF1A serves as the SL1 contact point for the UBF coactivator, a requirement for forming a transcriptionally active, UBF-responsive complex [PMID:7491500], and it nucleates additional preinitiation complex contacts by directly binding PAF49/ASE-1 and DCAF13, the latter being required for PIC assembly at the rDNA promoter and downstream ribosome biogenesis [PMID:15226435, PMID:40902972]. Its C-terminal 51 residues constitute a nuclear/nucleolar localization signal that engages multiple beta-karyopherin import receptors in a Ran-dependent manner [PMID:15113842]. TAF1A activity is developmentally and regulatorily tuned — its abundance falls during F9 cell differentiation in parallel with reduced Pol I transcription [PMID:9933634], and its promoter recruitment can be scaffolded by the lncRNA LINC01116 to drive oncogenic Pol I output [PMID:39369230]. Compound heterozygous recessive TAF1A mutations cause pediatric dilated cardiomyopathy with nucleolar segregation defects, a cardiac ribosomopathy recapitulated by zebrafish knockout [PMID:28472305].","teleology":[{"year":1994,"claim":"Established that promoter DNA recognition in the Pol I preinitiation complex resides in the TAF subunits rather than TBP, answering how species-specific rDNA promoter selectivity is achieved.","evidence":"UV crosslinking and chimeric SL1/TIF-IB reconstitution with in vitro transcription","pmids":["8013460"],"confidence":"High","gaps":["Did not define the DNA sequence specificity contributed by TAF1A versus the other DNA-binding TAF","No structural model of the TAF1A-DNA interface"]},{"year":1994,"claim":"Demonstrated that TAF1A is a direct TBP-binding subunit and that the TBP core domain alone suffices to assemble all three TAFs, defining the architectural core of SL1.","evidence":"In vitro protein interaction assay, immunopurification of tagged TBP complexes, in vitro transcription","pmids":["8058785"],"confidence":"High","gaps":["Did not map the precise TBP interaction surface","Stoichiometry within SL1 not resolved"]},{"year":1995,"claim":"Identified TAF1A as both the UBF coactivator target and a class-specific selectivity factor, explaining how SL1 is rendered UBF-responsive and Pol II-incompatible.","evidence":"In vitro transcription reconstitution and protein interaction/promoter contact assays with purified components","pmids":["7491500"],"confidence":"High","gaps":["Did not define the TAF1A-UBF binding interface","Mechanism by which TAF1A alters TBP TATA-box engagement not structurally resolved"]},{"year":1997,"claim":"Showed that a viral activator (SV40 large T antigen) exploits TAF1A to stimulate Pol I transcription, demonstrating TAF1A as a recruitment hub for transcriptional activators.","evidence":"Reciprocal immunoprecipitation in vitro and in infected cells plus in vitro transcription with T antigen deletion mutants","pmids":["9203586"],"confidence":"High","gaps":["Did not isolate the TAF1A-specific contribution to T antigen binding from TBP/TAF110","Physiological (non-viral) activators using this surface not identified here"]},{"year":1999,"claim":"Linked TAF1A abundance to developmental control of rRNA synthesis, showing rDNA transcription can be tuned by SL1 subunit availability.","evidence":"F9 embryonal carcinoma differentiation model with SL1 subunit quantification and in vitro transcription","pmids":["9933634"],"confidence":"Medium","gaps":["Did not establish whether TAF1A loss is causal versus correlative for the transcription decline","Mechanism controlling TAF1A levels during differentiation unknown"]},{"year":2004,"claim":"Mapped the molecular interfaces of TAF1A — the C-terminal TBP-binding domain engaging TBP helix 2, a C-terminal nuclear/nucleolar import signal, and direct binding to PAF49/ASE-1 — resolving how TAF1A docks TBP, reaches the nucleolus, and extends SL1 contacts.","evidence":"Yeast two-hybrid and mutagenesis (TBP interface), GFP domain-deletion with importin co-precipitation and Ran-dependence (NLS), co-IP with domain mapping (PAF49)","pmids":["15315821","15113842","15226435"],"confidence":"Medium","gaps":["Single-lab interaction mapping without structural confirmation","Functional consequence of distinct importin usage in vivo not dissected"]},{"year":2006,"claim":"Placed nucleophosmin upstream of cell-cycle-dependent TAF1A expression, implicating TAF1A in G2/M regulation of the rDNA transcription machinery.","evidence":"siRNA depletion of NPM with expression profiling and cell cycle analysis","pmids":["17069796"],"confidence":"Low","gaps":["Single indirect measure of TAF1A mRNA, no direct mechanism on TAF1A protein function","Whether NPM acts directly on the TAF1A promoter not shown"]},{"year":2017,"claim":"Connected TAF1A loss-of-function to human disease, establishing it as a cardiac ribosomopathy gene through impaired rRNA synthesis.","evidence":"Whole exome sequencing of affected sisters, cardiomyocyte nucleolar segregation pathology, zebrafish knockout cardiac phenotyping","pmids":["28472305"],"confidence":"Medium","gaps":["Causality rests on two-sibling family plus model organism","Tissue specificity of the cardiac phenotype despite ubiquitous Pol I role unexplained"]},{"year":2024,"claim":"Identified lncRNA scaffolding (LINC01116) as a mechanism recruiting TAF1A to the rDNA promoter to amplify Pol I transcription in cancer.","evidence":"RIP, ChIRP, ChIP, and lncRNA knockdown/overexpression with Pol I transcription readout in lung adenocarcinoma cells","pmids":["39369230"],"confidence":"Medium","gaps":["Direct TAF1A-LINC01116 contact versus indirect association not fully resolved","Single cancer context"]},{"year":2025,"claim":"Defined DCAF13 as a direct TAF1A partner required for Pol I preinitiation complex assembly, adding a new regulator of SL1-dependent transcription.","evidence":"Co-immunoprecipitation and DCAF13 knockdown assays of rDNA transcription, ribosome biogenesis, and protein synthesis","pmids":["40902972"],"confidence":"Medium","gaps":["TAF1A domain bound by DCAF13 not mapped","Single-lab co-IP without reciprocal structural validation"]},{"year":null,"claim":"How the multiple TAF1A interaction surfaces (DNA, TBP, UBF, PAF49, DCAF13) are spatially and temporally coordinated within an assembling Pol I PIC, and why TAF1A deficiency manifests preferentially in the heart, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No high-resolution structure of TAF1A within SL1","Tissue-specific vulnerability to TAF1A loss unexplained","Integration of regulatory inputs (NPM, lncRNA, differentiation) into a unified model lacking"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[1]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,2,5]}],"localization":[{"term_id":"GO:0005730","term_label":"nucleolus","supporting_discovery_ids":[6,8]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[6]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,1]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[9]}],"complexes":["SL1/TIF-IB"],"partners":["TBP","UBF","PAF49/ASE-1","DCAF13","SV40 LARGE T ANTIGEN"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q15573","full_name":"TATA box-binding protein-associated factor RNA polymerase I subunit A","aliases":["RNA polymerase I-specific TBP-associated factor 48 kDa","TAFI48","TATA box-binding protein-associated factor 1A","TBP-associated factor 1A","Transcription factor SL1","Transcription initiation factor SL1/TIF-IB subunit A"],"length_aa":450,"mass_kda":52.7,"function":"Component of the transcription factor SL1/TIF-IB complex, which is involved in the assembly of the PIC (pre-initiation complex) during RNA polymerase I-dependent transcription. The rate of PIC formation probably is primarily dependent on the rate of association of SL1/TIF-IB with the rDNA promoter. SL1/TIF-IB is involved in stabilization of nucleolar transcription factor 1/UBTF on rDNA. Formation of SL1/TIF-IB excludes the association of TBP with TFIID subunits","subcellular_location":"Nucleus, nucleolus","url":"https://www.uniprot.org/uniprotkb/Q15573/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/TAF1A","classification":"Common Essential","n_dependent_lines":697,"n_total_lines":1208,"dependency_fraction":0.5769867549668874},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"TBP","stoichiometry":0.2},{"gene":"TSG101","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/TAF1A","total_profiled":1310},"omim":[{"mim_id":"612823","title":"TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 1D; TAF1D","url":"https://www.omim.org/entry/612823"},{"mim_id":"604905","title":"TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 1C; TAF1C","url":"https://www.omim.org/entry/604905"},{"mim_id":"604904","title":"TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 1B; TAF1B","url":"https://www.omim.org/entry/604904"},{"mim_id":"604903","title":"TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 1A; TAF1A","url":"https://www.omim.org/entry/604903"},{"mim_id":"107325","title":"POLYMERASE I, RNA, SUBUNIT G; POLR1G","url":"https://www.omim.org/entry/107325"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Microtubules","reliability":"Approved"},{"location":"Primary cilium","reliability":"Additional"},{"location":"Primary cilium tip","reliability":"Additional"},{"location":"Primary cilium transition zone","reliability":"Additional"},{"location":"Basal body","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/TAF1A"},"hgnc":{"alias_symbol":["TAFI48","SL1"],"prev_symbol":[]},"alphafold":{"accession":"Q15573","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q15573","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q15573-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q15573-F1-predicted_aligned_error_v6.png","plddt_mean":85.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TAF1A","jax_strain_url":"https://www.jax.org/strain/search?query=TAF1A"},"sequence":{"accession":"Q15573","fasta_url":"https://rest.uniprot.org/uniprotkb/Q15573.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q15573/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q15573"}},"corpus_meta":[{"pmid":"7491500","id":"PMC_7491500","title":"Coactivator and promoter-selective properties of RNA polymerase I TAFs.","date":"1995","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/7491500","citation_count":86,"is_preprint":false},{"pmid":"27878435","id":"PMC_27878435","title":"Novel phenotypes and loci identified through clinical genomics approaches to pediatric cataract.","date":"2016","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27878435","citation_count":75,"is_preprint":false},{"pmid":"8702872","id":"PMC_8702872","title":"RRN11 encodes the third subunit of the complex containing Rrn6p and Rrn7p that is essential for the initiation of rDNA transcription by yeast RNA polymerase I.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8702872","citation_count":70,"is_preprint":false},{"pmid":"8013460","id":"PMC_8013460","title":"TBP-associated factors interact with DNA and govern species specificity of RNA polymerase I transcription.","date":"1994","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8013460","citation_count":60,"is_preprint":false},{"pmid":"9203586","id":"PMC_9203586","title":"SV40 large T antigen binds to the TBP-TAF(I) complex SL1 and coactivates ribosomal RNA transcription.","date":"1997","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/9203586","citation_count":54,"is_preprint":false},{"pmid":"29367541","id":"PMC_29367541","title":"Diagnostic Yield of Whole Exome Sequencing in Pediatric Dilated Cardiomyopathy.","date":"2017","source":"Journal of cardiovascular development and disease","url":"https://pubmed.ncbi.nlm.nih.gov/29367541","citation_count":47,"is_preprint":false},{"pmid":"28777933","id":"PMC_28777933","title":"Heterozygous De Novo UBTF Gain-of-Function Variant Is Associated with Neurodegeneration in Childhood.","date":"2017","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28777933","citation_count":42,"is_preprint":false},{"pmid":"15226435","id":"PMC_15226435","title":"Multiple protein-protein interactions by RNA polymerase I-associated factor PAF49 and role of PAF49 in rRNA transcription.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15226435","citation_count":35,"is_preprint":false},{"pmid":"28472305","id":"PMC_28472305","title":"Recessive TAF1A mutations reveal ribosomopathy in siblings with end-stage pediatric dilated cardiomyopathy.","date":"2017","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28472305","citation_count":22,"is_preprint":false},{"pmid":"8058785","id":"PMC_8058785","title":"The conserved core domain of the human TATA binding protein is sufficient to assemble the multisubunit RNA polymerase I-specific transcription factor SL1.","date":"1994","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8058785","citation_count":19,"is_preprint":false},{"pmid":"12095692","id":"PMC_12095692","title":"Characterization of a fission yeast subunit of an RNA polymerase I essential transcription initiation factor, SpRrn7h/TAF(I)68, that bridges yeast and mammals: association with SpRrn11h and the core ribosomal RNA gene promoter.","date":"2002","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/12095692","citation_count":19,"is_preprint":false},{"pmid":"17069796","id":"PMC_17069796","title":"Global functional analysis of nucleophosmin in Taxol response, cancer, chromatin regulation, and ribosomal DNA transcription.","date":"2006","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/17069796","citation_count":18,"is_preprint":false},{"pmid":"33311601","id":"PMC_33311601","title":"TAF1A and ZBTB41 serve as novel key genes in cervical cancer identified by integrated approaches.","date":"2020","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33311601","citation_count":13,"is_preprint":false},{"pmid":"26811294","id":"PMC_26811294","title":"Detection of genes associated with developmental competence of bovine oocytes.","date":"2016","source":"Animal reproduction science","url":"https://pubmed.ncbi.nlm.nih.gov/26811294","citation_count":12,"is_preprint":false},{"pmid":"9933634","id":"PMC_9933634","title":"Regulation of RNA polymerase I transcription in response to F9 embryonal carcinoma stem cell differentiation.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9933634","citation_count":11,"is_preprint":false},{"pmid":"25551296","id":"PMC_25551296","title":"Frameshift mutations of TAF1C gene, a core component for transcription by RNA polymerase I, and its regional heterogeneity in gastric and colorectal cancers.","date":"2015","source":"Pathology","url":"https://pubmed.ncbi.nlm.nih.gov/25551296","citation_count":11,"is_preprint":false},{"pmid":"10894955","id":"PMC_10894955","title":"Genomic localization of the human genes TAF1A, TAF1B and TAF1C, encoding TAF(I)48, TAF(I)63 and TAF(I)110 subunits of class I general transcription initiation factor SL1.","date":"2000","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10894955","citation_count":7,"is_preprint":false},{"pmid":"15113842","id":"PMC_15113842","title":"The carboxyl-terminus directs TAF(I)48 to the nucleus and nucleolus and associates with multiple nuclear import receptors.","date":"2004","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15113842","citation_count":7,"is_preprint":false},{"pmid":"39993547","id":"PMC_39993547","title":"Key genes linking gut microbiota, immune cells, and osteoporosis: A multi-omics approach.","date":"2025","source":"Microbial pathogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/39993547","citation_count":7,"is_preprint":false},{"pmid":"15315821","id":"PMC_15315821","title":"Identification of a domain within human TAF(I)48, a subunit of Selectivity Factor 1, that interacts with helix 2 of TBP.","date":"2004","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/15315821","citation_count":4,"is_preprint":false},{"pmid":"39369230","id":"PMC_39369230","title":"LINC01116-dependent upregulation of RNA polymerase I transcription drives oncogenic phenotypes in lung adenocarcinoma.","date":"2024","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39369230","citation_count":4,"is_preprint":false},{"pmid":"36786723","id":"PMC_36786723","title":"Acute hypoxia attenuates resistance exercise-induced ribosome signaling but does not impact satellite cell pool expansion in human skeletal muscle.","date":"2023","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/36786723","citation_count":4,"is_preprint":false},{"pmid":"17954271","id":"PMC_17954271","title":"Transcriptional profiling of genes at the human common fragile site FRA1H in tumor-derived cell lines.","date":"2007","source":"Cancer genetics and cytogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/17954271","citation_count":4,"is_preprint":false},{"pmid":"39175876","id":"PMC_39175876","title":"CRISPR-Cas9 screening develops an epigenetic and transcriptional gene signature for risk stratification and target prediction in neuroblastoma.","date":"2024","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/39175876","citation_count":3,"is_preprint":false},{"pmid":"35925837","id":"PMC_35925837","title":"TFIIB-related factor 1 is a nucleolar protein that promotes RNA polymerase I-directed transcription and tumour cell growth.","date":"2023","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35925837","citation_count":2,"is_preprint":false},{"pmid":"39209150","id":"PMC_39209150","title":"Biallelic potential disease-causing missense variants in TAF1A in two siblings with infantile restrictive cardiomyopathy.","date":"2024","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/39209150","citation_count":1,"is_preprint":false},{"pmid":"37501913","id":"PMC_37501913","title":"Juvenile-onset multifocal atrial arrhythmias, atrial standstill and compound heterozygosity of genetic variants in TAF1A: sentinel event for evolving dilated cardiomyopathy-a case report.","date":"2023","source":"European heart journal. Case reports","url":"https://pubmed.ncbi.nlm.nih.gov/37501913","citation_count":1,"is_preprint":false},{"pmid":"40902972","id":"PMC_40902972","title":"Nucleolar protein DCAF13 promotes non-small cell lung cancer cell proliferation via facilitating rDNA transcription and ribosome biogenesis.","date":"2025","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/40902972","citation_count":1,"is_preprint":false},{"pmid":"41588282","id":"PMC_41588282","title":"LncRNA TAF1A-AS1 regulates the progression in hepatocellular carcinoma by targeting miR-664b-3p/USP22 axis.","date":"2026","source":"Discover oncology","url":"https://pubmed.ncbi.nlm.nih.gov/41588282","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":16059,"output_tokens":2894,"usd":0.045794,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":10288,"output_tokens":3514,"usd":0.069645,"stage2_stop_reason":"end_turn"},"total_usd":0.115439,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"TAFI48 (TAF1A) serves as a direct target for interaction with UBF within the SL1 complex and is required to form a transcriptionally active SL1 complex responsive to UBF in vitro; additionally, TAFI48 alters TBP's ability to interact with TATA box elements such that the resulting complex fails to support RNA polymerase II transcription, establishing TAFI48 as both a UBF coactivator target and a class-specific promoter selectivity factor.\",\n      \"method\": \"In vitro transcription assays, protein-protein interaction assays, promoter contact studies\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro transcription reconstitution with purified components, multiple functional readouts, foundational study replicated conceptually by subsequent work\",\n      \"pmids\": [\"7491500\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"UV crosslinking experiments demonstrated that TAFI48 directly contacts the ribosomal gene promoter DNA, establishing it as one of two TAFs responsible for promoter DNA binding within the SL1/TIF-IB complex. This DNA-binding activity of the TAFs (not TBP's N-terminal domain) underlies species-specific rDNA promoter selectivity.\",\n      \"method\": \"UV crosslinking, chimeric SL1 complex reconstitution, in vitro transcription\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct UV crosslinking to promoter DNA with reconstituted complexes; mechanistic conclusion supported by multiple experimental approaches in one study\",\n      \"pmids\": [\"8013460\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"In vitro protein-protein interaction assay demonstrated that TBP directly interacts with the smallest TAF subunit TAFI48; furthermore, the conserved core domain of TBP alone (lacking the N-terminal domain) is sufficient to assemble an SL1 complex containing all three TAFs including TAFI48.\",\n      \"method\": \"In vitro protein-protein interaction assay, immunopurification of epitope-tagged TBP complexes, in vitro transcription\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro binding assay plus functional transcription reconstitution, multiple orthogonal methods\",\n      \"pmids\": [\"8058785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"SV40 large T antigen directly binds TAF(I)48 (as well as TBP and TAF(I)110) within the SL1 complex, both in vitro and in SV40-infected cells; large T antigen mutants that no longer bind SL1 also fail to stimulate Pol I transcription, establishing that T antigen recruitment to the rRNA promoter via SL1/TAF(I)48 is required for Pol I transcriptional activation.\",\n      \"method\": \"Immunoprecipitation (in vitro and in infected cells), in vitro transcription with T antigen deletion mutants\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — reciprocal immunoprecipitation in vitro and in vivo, combined with functional transcription assays using deletion mutants establishing necessity\",\n      \"pmids\": [\"9203586\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The abundance of TAFI48 (along with TAFI95) decreases during differentiation of F9 embryonal carcinoma cells into parietal endoderm, and this reduction is associated with decreased RNA polymerase I transcription, demonstrating that developmental regulation of rRNA synthesis is achieved in part through changes in TAFI48 availability.\",\n      \"method\": \"Cell differentiation model, quantification of SL1 subunit levels, in vitro transcription\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — defined cellular differentiation model with measurement of both protein levels and transcriptional output, single lab\",\n      \"pmids\": [\"9933634\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"TAF(I)48 directly interacts with the N-terminal segment of the Pol I-associated factor PAF49/ASE-1; this interaction also co-precipitates other SL1 components, linking PAF49 to the SL1 complex through TAF(I)48.\",\n      \"method\": \"Coimmunoprecipitation, domain-mapping of PAF49, in vitro protein interaction assays, in vitro transcription with inhibitory antibody\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — coimmunoprecipitation with domain mapping and functional transcription assay, single lab\",\n      \"pmids\": [\"15226435\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The carboxyl-terminal 51 residues of TAF(I)48 are necessary and sufficient for nuclear and nucleolar localization; this region also associates with multiple beta-karyopherin nuclear import receptors (importin beta/karyopherin beta1, transportin/karyopherin beta2, RanBP5/karyopherin beta3) in a Ran-dependent manner, identifying the first nuclear import sequence within an SL1 TAF subunit.\",\n      \"method\": \"GFP fusion domain-deletion analysis, co-precipitation with importins, Ran-dependence assay, immunolocalization\",\n      \"journal\": \"Journal of biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct subcellular localization with domain deletion and multiple importin binding assays, single lab\",\n      \"pmids\": [\"15113842\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"A TBP-binding domain was mapped to the carboxyl-terminus of human TAF(I)48; mutagenesis of uncharged and positive residues in this region disrupted TBP binding; TBP residues within and adjacent to helix 2 (previously shown to contact TFIID and TFIIIB subunits) also reduced affinity for the TAF(I)48 carboxyl-terminus.\",\n      \"method\": \"Yeast two-hybrid, direct protein-protein interaction assay, site-directed mutagenesis of both TAF(I)48 and TBP\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis combined with direct binding assay, but single lab and abstract-level detail\",\n      \"pmids\": [\"15315821\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Compound heterozygous recessive mutations in TAF1A in two sisters with end-stage pediatric dilated cardiomyopathy were associated with gene-specific nucleolar segregation defects in cardiomyocytes (indicative of impaired rRNA synthesis); knockout of the homologous gene in zebrafish recapitulated heart failure with pericardial edema, decreased ventricular systolic function, and embryonic mortality.\",\n      \"method\": \"Whole exome sequencing, cardiac histopathology (nucleolar segregation), zebrafish knockout with cardiac phenotype readout\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function in zebrafish with defined cardiac phenotype plus human tissue pathology, single lab\",\n      \"pmids\": [\"28472305\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"DCAF13 directly interacts with TAF1A, a component of the RNA polymerase I preinitiation complex, and this interaction is necessary for preinitiation complex assembly at the rDNA promoter; DCAF13 knockdown impairs rDNA transcription, ribosome biogenesis, and protein synthesis.\",\n      \"method\": \"Co-immunoprecipitation (direct interaction), knockdown functional assays (rDNA transcription, ribosome biogenesis, protein synthesis)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding demonstrated by co-IP with functional knockdown readouts, single lab\",\n      \"pmids\": [\"40902972\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"The lncRNA LINC01116 scaffolds TAF1A and TAF1D to the ribosomal DNA promoter, as demonstrated by RNA immunoprecipitation and chromatin isolation by RNA purification (ChIRP); this scaffolding activity upregulates Pol I transcription and drives oncogenic phenotypes in lung adenocarcinoma cells.\",\n      \"method\": \"RNA immunoprecipitation, ChIRP, ChIP, lncRNA knockdown/overexpression with Pol I transcription readout\",\n      \"journal\": \"Journal of translational medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal chromatin/RNA binding methods, single lab\",\n      \"pmids\": [\"39369230\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Nucleophosmin (NPM) is required for a G2/M upregulation of TAF1A mRNA; siRNA depletion of NPM abolishes this cell-cycle-dependent increase in TAF1A expression, placing NPM upstream of TAF1A in the regulation of rDNA transcription machinery.\",\n      \"method\": \"siRNA knockdown of NPM, microarray and gene expression profiling, cell cycle analysis\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single indirect measure of TAF1A mRNA regulation, no direct mechanistic dissection of TAF1A protein function\",\n      \"pmids\": [\"17069796\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TAF1A (TAFI48) is the 48-kDa subunit of the RNA polymerase I-specific promoter selectivity factor SL1, where it directly contacts rDNA promoter sequences, serves as the target for UBF coactivator interaction to enable UBF-responsive Pol I transcription, directly binds TBP through its carboxyl-terminal domain (engaging TBP helix 2), associates with PAF49/ASE-1 and DCAF13 to facilitate preinitiation complex assembly, and is directed to the nucleolus via a C-terminal nuclear localization sequence that engages multiple beta-karyopherin importins; loss of TAF1A function in humans and zebrafish causes impaired rRNA synthesis with cardiac ribosomopathy phenotypes.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"TAF1A (TAFI48) is a TBP-associated subunit of the RNA polymerase I promoter selectivity factor SL1, where it confers class-specific recognition of the ribosomal RNA gene promoter and couples this machinery to transcriptional activation [#0, #1]. Within SL1 it directly contacts rDNA promoter DNA, an activity (rather than TBP's N-terminus) that underlies species-specific promoter selectivity [#1], and it binds TBP through its carboxyl-terminal domain engaging residues in and around TBP helix 2, while also remodeling TBP so the resulting complex no longer supports Pol II transcription [#0, #7]. TAF1A serves as the SL1 contact point for the UBF coactivator, a requirement for forming a transcriptionally active, UBF-responsive complex [#0], and it nucleates additional preinitiation complex contacts by directly binding PAF49/ASE-1 and DCAF13, the latter being required for PIC assembly at the rDNA promoter and downstream ribosome biogenesis [#5, #9]. Its C-terminal 51 residues constitute a nuclear/nucleolar localization signal that engages multiple beta-karyopherin import receptors in a Ran-dependent manner [#6]. TAF1A activity is developmentally and regulatorily tuned — its abundance falls during F9 cell differentiation in parallel with reduced Pol I transcription [#4], and its promoter recruitment can be scaffolded by the lncRNA LINC01116 to drive oncogenic Pol I output [#10]. Compound heterozygous recessive TAF1A mutations cause pediatric dilated cardiomyopathy with nucleolar segregation defects, a cardiac ribosomopathy recapitulated by zebrafish knockout [#8].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Established that promoter DNA recognition in the Pol I preinitiation complex resides in the TAF subunits rather than TBP, answering how species-specific rDNA promoter selectivity is achieved.\",\n      \"evidence\": \"UV crosslinking and chimeric SL1/TIF-IB reconstitution with in vitro transcription\",\n      \"pmids\": [\"8013460\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the DNA sequence specificity contributed by TAF1A versus the other DNA-binding TAF\", \"No structural model of the TAF1A-DNA interface\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Demonstrated that TAF1A is a direct TBP-binding subunit and that the TBP core domain alone suffices to assemble all three TAFs, defining the architectural core of SL1.\",\n      \"evidence\": \"In vitro protein interaction assay, immunopurification of tagged TBP complexes, in vitro transcription\",\n      \"pmids\": [\"8058785\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not map the precise TBP interaction surface\", \"Stoichiometry within SL1 not resolved\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Identified TAF1A as both the UBF coactivator target and a class-specific selectivity factor, explaining how SL1 is rendered UBF-responsive and Pol II-incompatible.\",\n      \"evidence\": \"In vitro transcription reconstitution and protein interaction/promoter contact assays with purified components\",\n      \"pmids\": [\"7491500\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the TAF1A-UBF binding interface\", \"Mechanism by which TAF1A alters TBP TATA-box engagement not structurally resolved\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Showed that a viral activator (SV40 large T antigen) exploits TAF1A to stimulate Pol I transcription, demonstrating TAF1A as a recruitment hub for transcriptional activators.\",\n      \"evidence\": \"Reciprocal immunoprecipitation in vitro and in infected cells plus in vitro transcription with T antigen deletion mutants\",\n      \"pmids\": [\"9203586\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not isolate the TAF1A-specific contribution to T antigen binding from TBP/TAF110\", \"Physiological (non-viral) activators using this surface not identified here\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Linked TAF1A abundance to developmental control of rRNA synthesis, showing rDNA transcription can be tuned by SL1 subunit availability.\",\n      \"evidence\": \"F9 embryonal carcinoma differentiation model with SL1 subunit quantification and in vitro transcription\",\n      \"pmids\": [\"9933634\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not establish whether TAF1A loss is causal versus correlative for the transcription decline\", \"Mechanism controlling TAF1A levels during differentiation unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Mapped the molecular interfaces of TAF1A — the C-terminal TBP-binding domain engaging TBP helix 2, a C-terminal nuclear/nucleolar import signal, and direct binding to PAF49/ASE-1 — resolving how TAF1A docks TBP, reaches the nucleolus, and extends SL1 contacts.\",\n      \"evidence\": \"Yeast two-hybrid and mutagenesis (TBP interface), GFP domain-deletion with importin co-precipitation and Ran-dependence (NLS), co-IP with domain mapping (PAF49)\",\n      \"pmids\": [\"15315821\", \"15113842\", \"15226435\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab interaction mapping without structural confirmation\", \"Functional consequence of distinct importin usage in vivo not dissected\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Placed nucleophosmin upstream of cell-cycle-dependent TAF1A expression, implicating TAF1A in G2/M regulation of the rDNA transcription machinery.\",\n      \"evidence\": \"siRNA depletion of NPM with expression profiling and cell cycle analysis\",\n      \"pmids\": [\"17069796\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single indirect measure of TAF1A mRNA, no direct mechanism on TAF1A protein function\", \"Whether NPM acts directly on the TAF1A promoter not shown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Connected TAF1A loss-of-function to human disease, establishing it as a cardiac ribosomopathy gene through impaired rRNA synthesis.\",\n      \"evidence\": \"Whole exome sequencing of affected sisters, cardiomyocyte nucleolar segregation pathology, zebrafish knockout cardiac phenotyping\",\n      \"pmids\": [\"28472305\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causality rests on two-sibling family plus model organism\", \"Tissue specificity of the cardiac phenotype despite ubiquitous Pol I role unexplained\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identified lncRNA scaffolding (LINC01116) as a mechanism recruiting TAF1A to the rDNA promoter to amplify Pol I transcription in cancer.\",\n      \"evidence\": \"RIP, ChIRP, ChIP, and lncRNA knockdown/overexpression with Pol I transcription readout in lung adenocarcinoma cells\",\n      \"pmids\": [\"39369230\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct TAF1A-LINC01116 contact versus indirect association not fully resolved\", \"Single cancer context\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Defined DCAF13 as a direct TAF1A partner required for Pol I preinitiation complex assembly, adding a new regulator of SL1-dependent transcription.\",\n      \"evidence\": \"Co-immunoprecipitation and DCAF13 knockdown assays of rDNA transcription, ribosome biogenesis, and protein synthesis\",\n      \"pmids\": [\"40902972\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"TAF1A domain bound by DCAF13 not mapped\", \"Single-lab co-IP without reciprocal structural validation\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the multiple TAF1A interaction surfaces (DNA, TBP, UBF, PAF49, DCAF13) are spatially and temporally coordinated within an assembling Pol I PIC, and why TAF1A deficiency manifests preferentially in the heart, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No high-resolution structure of TAF1A within SL1\", \"Tissue-specific vulnerability to TAF1A loss unexplained\", \"Integration of regulatory inputs (NPM, lncRNA, differentiation) into a unified model lacking\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [1]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 2, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [6, 8]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [9]}\n    ],\n    \"complexes\": [\"SL1/TIF-IB\"],\n    \"partners\": [\"TBP\", \"UBF\", \"PAF49/ASE-1\", \"DCAF13\", \"SV40 large T antigen\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}